ESG Inc. Files S-1 for Public Offering
Ticker: ESGH · Form: S-1 · Filed: Aug 21, 2024 · CIK: 1883835
Sentiment: neutral
Topics: ipo, registration-statement, sec-filing
TL;DR
ESG Inc. just filed an S-1, looks like they're going public soon.
AI Summary
ESG Inc., formerly PLASMA INNOVATIVE INC., filed an S-1 registration statement on August 21, 2024. The company, incorporated in Nevada with its principal business address in Kennett Square, PA, operates in the biological products sector. This filing indicates the company is preparing for a public offering of its securities.
Why It Matters
This S-1 filing signals ESG Inc.'s intention to raise capital through the public markets, which could fund future growth and development in the biological products industry.
Risk Assessment
Risk Level: medium — As an S-1 filing, it represents a company in the process of going public, which inherently carries risks associated with market reception and operational scaling.
Key Numbers
- 20240821 — Filing Date (The date ESG Inc. submitted its S-1 filing to the SEC.)
- 1231 — Fiscal Year End (Indicates the end of ESG Inc.'s financial reporting year.)
Key Players & Entities
- ESG Inc. (company) — Filer of the S-1 document
- PLASMA INNOVATIVE INC. (company) — Former name of ESG Inc.
- 20240821 (date) — Date of filing
- Nevada (jurisdiction) — State of incorporation
- Kennett Square, PA (location) — Business address
- BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) (industry) — Company's Standard Industrial Classification
FAQ
What is the primary purpose of this S-1 filing for ESG Inc.?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, indicating ESG Inc.'s intention to go public.
When was ESG Inc. formerly known as?
ESG Inc. was formerly known as PLASMA INNOVATIVE INC., with a name change date of 20210920.
In which state is ESG Inc. incorporated?
ESG Inc. is incorporated in Nevada (NV).
What is ESG Inc.'s business address?
ESG Inc.'s business address is 523 SCHOOL HOUSE RD, KENNETT SQUARE, PA 19348.
What industry sector does ESG Inc. operate in?
ESG Inc. operates in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, with SIC code 2836.
Filing Stats: 4,586 words · 18 min read · ~15 pages · Grade level 13.4 · Accepted 2024-08-21 15:28:27
Key Financial Figures
- $5.00 — f Common Stock Offered by the Company $5.00 per share This is a public offering o
- $0.001 — offering of our common stock, par value $0.001 per share. We are selling 5,000,000 sha
Filing Documents
- esgh-20240816_s1.htm (S-1) — 1447KB
- esgh-20240816_s1ex5z1.htm (EX-5.1) — 8KB
- esgh-20240816_s1ex10z2.htm (EX-10) — 23KB
- esgh-20240816_s1ex23z2.htm (EX-23.2) — 1KB
- esgh-20240816_s1ex107.htm (EX-FILING FEES) — 19KB
- image_01.jpg (GRAPHIC) — 22KB
- image_02.jpg (GRAPHIC) — 101KB
- image_03.jpg (GRAPHIC) — 39KB
- 0001520138-24-000284.txt ( ) — 6376KB
- esgh-20240630.xsd (EX-101.SCH) — 41KB
- esgh-20240630_cal.xml (EX-101.CAL) — 63KB
- esgh-20240630_def.xml (EX-101.DEF) — 121KB
- esgh-20240630_lab.xml (EX-101.LAB) — 274KB
- esgh-20240630_pre.xml (EX-101.PRE) — 235KB
- esgh-20240816_s1_htm.xml (XML) — 923KB
RISK FACTORS
RISK FACTORS 13 CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS 36
USE OF PROCEEDS
USE OF PROCEEDS 38 DETERMINATION OF THE OFFERING PRICE 39
DILUTION
DILUTION 40 MARKET FOR REGISTRANT'S COMMON STOCK, DIVIDEND POLICY AND RELATED STOCKHOLDER MATTERS 41
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 42 MANAGEMENT, DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 47 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 57 PLAN OF DISTRIBUTION 59
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 60 EXPERTS 61 LEGAL MATTERS 61 WHERE YOU CAN FIND MORE INFORMATION 61 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS In making your investment decision, you should only rely on the information contained in this prospectus. We have not authorized anyone to provide you with any other or different information. If anyone provides you with information that is different from, or inconsistent with, the information in this prospectus, you should not rely on it. We believe the information in this prospectus is materially complete and correct as of the date on the front cover. We cannot, however, guarantee that the information will remain correct after that date. For that reason, you should assume that the information in this prospectus is accurate only as of the date on the front cover and that it may not still be accurate on a later date. This document may only be used where it is legal to sell these securities. The information contained in this prospectus is current only as of its date, regardless of the time of delivery of this prospectus or of any sales of our shares of common stock. You should not interpret the contents of this prospectus to be legal, business, investment or tax advice. You should consult with your own advisors for that type of advice and consult with them about the legal, tax, business, financial and other issues that you should consider before investing in our common stock. This prospectus does not offer to sell, or ask for offers to buy, any shares of our common stock in any state or other jurisdiction in which such offer or solicitation would be unlawful or where the person making the offer is not qualified to do so. No action is being taken in any jurisdictions outside the United States to permit a public offering of our common stock or possession or distribution of this prospectus in those jurisdictions. Persons who come into possession of this prospectus in jurisdictions outside the Uni